Not medical advice
πb/glp1Community for GLP-1
Return on investment of SGLT2 inhibitors and GLP-1 receptor agonists: Implications of real-world use for managed care
UNRATED
Community vote
No Bro-Meter votes yet. Be the first. The verdict is only these votes β not FDA pages, imports, or ads.
Tried-it reports
Lived experience sits next to the community vote. Official sources never override either.
Published in J Manag Care Spec Pharm. Imported from PubMed. This was filed by the system importer, not a fake user.
00
Votes and comments are community opinion, not professional advice.
Comments
No comments yet. Got receipts? Drop them.